WCBA
WST icon

Weaver C. Barksdale & Associates’s West Pharmaceutical WST Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9K Hold
88
– – 0.01% 303
2017
Q3 		$8K Buy
88
+4
+5% +$362 0.01% 321
2017
Q2 		$8K Sell
84
-15
-15% -$1.38K 0.01% 313
2017
Q1 		$8K Hold
99
– – 0.01% 324
2016
Q4 		$8K Buy
99
+14
+16% +$1.1K 0.01% 322
2016
Q3 		$6K Sell
85
-7
-8% -$556 0.01% 356
2016
Q2 		$7K Hold
92
– – 0.01% 316
2016
Q1 		$6K Hold
92
– – ﹤0.01% 364
2015
Q4 		$6K Sell
92
-13
-12% -$782 ﹤0.01% 358
2015
Q3 		$6K Buy
+105
New +$6.12K ﹤0.01% 358

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Weaver C. Barksdale & Associates's WST Position: Q4 2017 in Review

Weaver C. Barksdale & Associates held its West Pharmaceutical (WST) position steady in Q4 2017 at 88 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #303.

Weaver C. Barksdale & Associates first reported a position in WST in Q3 2015 and has held it in 10 quarters since. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

  • Weaver C. Barksdale & Associates held 88 shares of West Pharmaceutical worth $9K as of Q4 2017.
  • Weaver C. Barksdale & Associates left its West Pharmaceutical share count unchanged in Q4 2017.
  • West Pharmaceutical made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #303 holding.
  • Weaver C. Barksdale & Associates first reported a position in West Pharmaceutical in Q3 2015 and has held it in 10 quarters since.
  • 338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.